```html

Physiologic Newborn Jaundice – A Comprehensive Medical Guide

Overview

Physiologic jaundice is a common, usually harmless, condition that appears in many newborns during the first week of life. It results from a temporary buildup of bilirubin—a yellow pigment produced when red blood cells break down—in the infant’s blood. Because newborns have immature liver function and a higher turnover of red blood cells, bilirubin can accumulate faster than the liver can clear it.

Who it affects: Almost all full‑term infants (≥37 weeks gestation) experience some degree of jaundice. The condition is less common—but still possible—in preterm babies, who are at higher risk for severe jaundice because their livers are even less mature.

Prevalence: According to the American Academy of Pediatrics (AAP), up to 60 % of term infants develop visible jaundice, and about 10 % require phototherapy for physiologic jaundice alone.<sup>1</sup> In low‑ and middle‑income countries, the prevalence of severe hyperbilirubinemia (bilirubin > 20 mg/dL) is higher, affecting up to 8 % of newborns, largely because of delayed recognition and limited access to treatment.<sup>2</sup>

Symptoms

The hallmark of physiologic jaundice is a yellow discoloration of the skin and sclera (the white part of the eyes). The intensity and distribution follow a predictable pattern as bilirubin levels rise.

• Skin discoloration: Begins on the face (particularly the forehead and cheeks) and spreads downward to the chest, abdomen, arms, legs, and sometimes the soles of the feet. The yellow hue is most noticeable when the infant’s skin is pressed (blanching test).
• Scleral icterus: Yellowing of the whites of the eyes—often the earliest sign because the sclera has a thin layer of tissue.
• Feeding changes: Mild jaundice can make the baby seem slightly less hungry or more sleepy, but most infants maintain normal feeding patterns.
• Normal stool and urine: In physiologic jaundice, stool is yellow‑brown (often called “tarry‑yellow”) and urine is pale but not dark.
• Absence of other systemic signs: Unlike pathologic jaundice, there are no signs of infection, hemolysis, or metabolic disease (e.g., no fever, poor weight gain, or palpable liver/spleen).

Causes and Risk Factors

Physiologic jaundice is **multifactorial**. The main drivers are:

• Increased red‑cell breakdown: Newborns have a higher hematocrit and a shorter red‑blood‑cell lifespan (≈90 days vs. 120 days in adults), producing more bilirubin.
• Immature hepatic conjugation: The enzyme uridine diphosphate glucuronosyltransferase (UGT1A1) that converts bilirubin into a water‑soluble form matures over the first week of life, causing a temporary clearance lag.
• Enterohepatic recirculation: In the first days after birth, bilirubin can be re‑absorbed from the gut back into the bloodstream, especially if the infant has delayed meconium passage.

Risk Factors

• Prematurity (<37 weeks gestation)
• Breastfeeding difficulties (poor intake, delayed lactogenesis II)
• Exclusive breastfeeding without adequate milk transfer (often called “breast‑milk jaundice”)
• East Asian ethnicity (higher prevalence of UGT1A1 polymorphisms)<sup>3</sup>
• Cesarean delivery (delayed passage of meconium)
• Bruising or birth trauma (increased hemolysis)
• Family history of neonatal jaundice

Diagnosis

Diagnosis is primarily clinical, supported by simple, non‑invasive testing.

Physical Examination

• Visual assessment of skin and scleral coloration.
• Evaluation of the infant’s feeding pattern, weight trend, and stool/urine color.

Laboratory Tests

• Serum total bilirubin (TsB): A small heel‑stick blood sample measures total bilirubin. Levels are plotted on age‑specific phototherapy nomograms (the Bhutani “hour‑specific” curve) to decide if treatment is needed.<sup>4</sup>
• Direct (conjugated) bilirubin: Usually low (<2 mg/dL) in physiologic jaundice; a high direct fraction suggests cholestasis or other pathology.
• Optional: Complete blood count (CBC) and blood type/Coombs test if hemolysis is suspected.

Imaging (Rarely Needed)

Abdominal ultrasound may be ordered if there is concern for biliary obstruction or hepatic disease, but this is not typical for physiologic jaundice.

Treatment Options

Most cases of physiologic jaundice resolve spontaneously as the liver matures. Treatment is aimed at lowering bilirubin quickly enough to prevent neurotoxicity while supporting safe feeding.

Phototherapy

• How it works: Blue‑green light (≈420‑470 nm) converts bilirubin into water‑soluble isoforms that can be excreted without conjugation.
• Indications: TsB levels that cross the phototherapy threshold on the Bhutani nomogram, typically >12–15 mg/dL on day 2–3 for term infants.
• Types: Conventional overhead lamps, fiber‑optic blankets, or LED pads. LED devices are now standard because they are more efficient and generate less heat.
• Duration: Usually 6–24 hours, reassessed with serial bilirubin checks.

Exchange Transfusion (Rare)

Reserved for life‑threatening hyperbilirubinemia (>20 mg/dL in term infants) that does not respond to phototherapy. The procedure replaces the infant’s blood with donor blood, rapidly lowering bilirubin.

Supportive Measures

• Frequent feeding: 8–12 feeds per day (≈60–90 mL/kg/day) promotes bowel movements, decreasing enterohepatic recirculation.
• Supplemental formula: In exclusively breastfed infants who are not gaining weight, temporary supplementation with expressed breast milk or formula can reduce bilirubin levels.
• Sunlight exposure: Brief, indirect sunlight (5–10 minutes, 2–3 times daily) can modestly lower bilirubin, but is not a substitute for phototherapy and must be done safely to avoid sunburn.

Living with Jaundice of Newborn (Physiologic)

While the diagnosis can be stressful for parents, most infants recover without long‑term effects. Below are practical tips for daily management.

• Monitor feeding: Record the number of feeds, duration, and any signs of poor latch. Aim for at least 30 mL per feed for the first few days.
• Track urine and stool: Expect at least 6 wet diapers and 3–4 yellow stools per day by day 3. Dark urine or pale stools may signal worsening bilirubin.
• Skin checks: Use a handheld flashlight to assess the extent of yellowing every 12 hours. Note any spread from face to chest, abdomen, or limbs.
• Phototherapy care: Keep the infant’s eyes protected with soft, absorbent eye patches. Keep the skin clean and dry; change diapers frequently to prevent irritation.
• Family support: Encourage partners and other caregivers to assist with feeding and diaper changes so the mother can rest.
• Follow‑up appointments: Most hospitals arrange a bilirubin check before discharge and a follow‑up visit within 48–72 hours after going home.

Prevention

Because physiologic jaundice is a normal developmental phenomenon, it cannot be completely prevented, but risk can be reduced.

• Early and effective breastfeeding: Initiate nursing within the first hour of life if possible; use lactation support to ensure adequate milk transfer.
• Prompt cord clamping: Delayed cord clamping (≥30 seconds) slightly increases neonatal blood volume, which can raise bilirubin load; in high‑risk infants, early clamping may be considered after discussing benefits with the obstetric team.
• Encourage regular voiding and stooling: Early skin‑to‑skin contact and frequent feeds stimulate gut motility.
• Identify high‑risk infants: Babies born preterm, with a family history of severe jaundice, or of East Asian descent should be monitored closely.

Complications

When bilirubin levels become extremely high, bilirubin can cross the immature blood‑brain barrier, leading to:

• Kernicterus (bilirubin‑induced neurologic dysfunction): Permanent brain injury manifesting as movement disorders, hearing loss, and gaze palsy.
• Acute bilirubin encephalopathy: Reversible signs such as lethargy, poor feeding, high‑pitched cry, and muscle tone abnormalities.
• Chronic hemolytic anemia: Rarely, severe hemolysis may persist if an underlying disorder is missed.

These outcomes are exceedingly rare in physiologic jaundice when appropriate screening and treatment protocols are followed. The incidence of kernicterus in developed countries is <0.1 % of all newborns.<sup>5</sup>

When to Seek Emergency Care

References

1. American Academy of Pediatrics. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022;149(6):e2022059700.
2. World Health Organization. Neonatal Jaundice: Guidelines for the Management of Hyperbilirubinemia. WHO, 2021.
3. Nguyen TL, et al. Genetic variants of UGT1A1 and risk of neonatal jaundice in Asian populations. J Pediatr. 2020;222:112‑119.
4. Bhutani VK, Johnson L, et al. Predictive core of the hour‑specific bilirubin nomogram for healthy newborns. Pediatrics. 2004;114(1):e29‑e38.
5. Watchko JF. Neonatal hyperbilirubinemia: pathophysiology and treatment. Semin Perinatol. 2020;44(6):151‑161.

```